Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2008
11/06/2008US20080274265 Alleles of the prpd1 gene from coryneform bacteria
11/06/2008US20080274259 Delta-5 desaturases and their use in making polyunsaturated fatty acids
11/06/2008US20080274231 Papermaking, food, agriculture; genetic engineered polynucleotide; degradation of plant cell wall components; decomposition of plants and fruits
11/06/2008US20080274155 Chimeric Cannulae Proteins, Nucleic Acids Encoding Them And Methods For Making And Using Them
11/06/2008US20080274145 whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
11/06/2008US20080274143 Chloroplasts Engineering to Express Pharmaceutical Proteins
11/06/2008US20080274142 Hinge (hydrophobic pocket) region mutation attenuation; decreased viscerotropism; vaccines
11/06/2008US20080274139 Attenuated microorganisms for the treatment of infection
11/06/2008US20080274137 to improve expression of exogenous polypeptides, such as antigen, epitope, immunogen, peptide or polypeptide of interest; insertion of transposon between kanamycin resistance gene promoter and translation initiation abolished kanamycin resistance and unexpectedly enabled high rates of plasmid replication
11/06/2008US20080274133 Soluble Bifunctional Proteins
11/06/2008US20080274132 Vaccines for blocking transmission of plasmodium vivax
11/06/2008US20080274131 Molecular antigen arrary
11/06/2008US20080274130 Rabies Virus Vector Systems and Compositions and Methods Thereof
11/06/2008US20080274128 Heat shock protein-based vaccines and immunotherapies
11/06/2008US20080274126 Oral Vaccines for Fish
11/06/2008US20080274123 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy
11/06/2008US20080274116 Lipids, Lipid Complexes and Use Thereof
11/06/2008US20080274113 Immunoglobulin specific to actin-myosin machinery of malarial parasite; prevention protozoal diseases
11/06/2008US20080274111 Pancreatic Cancer Genes
11/06/2008US20080274110 Minibodies for use in treatment and prevention of cell proliferative and/or autoimmune disorders
11/06/2008US20080274109 Nucleotide sequences coding chemokines for use in dianosis of infection, arteriosclerosis, autoimmune, inflammatory, allergic and arthritic disorders
11/06/2008US20080274105 Polypeptide variants with altered effector function
11/06/2008US20080274104 Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics
11/06/2008US20080274099 Oncofoetal domain specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
11/06/2008US20080274091 Using lentiviral vector to transduce hematopoietic system and/or hematopoietic stem cells; improving heterologous gene expression; gene and tissue targeted therapies
11/06/2008US20080274081 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/06/2008US20080274077 Using Nogo receptor suppressant as therapeutic in treatment of nervous system and neurodegenerative disorders; axonal regeneration
11/06/2008US20080274059 Mite fusion proteins
11/06/2008US20080274055 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells
11/06/2008US20080274045 Imaging, diagnosis and treatment of disease
11/06/2008US20080274016 Biosensor and method of manufacturing biosensor
11/06/2008DE19737917B4 Verfahren zum Nachweis klinisch relevanter Veränderungen der DNS-Sequenz des Ki-ras-Onkogens, seine Verwendung und Testkit zur Früherkennung von Tumoren Method for the detection of clinically relevant changes in the DNA sequence of the Ki-ras oncogene, its use and test kit for early detection of tumors
11/06/2008DE102007021001A1 Expressionssystem zur antibiotikafreien Produktion von Polypeptiden Expression system for antibiotic-free production of polypeptides
11/06/2008DE10138876B4 Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung Genetically modified cyclic-nucleotide-gated ion channels, and their use
11/06/2008CA2698117A1 Fig4 gene mutations in neurodegeneration
11/06/2008CA2688514A1 Rna interference suppression of neurodegenerative diseases and methods of use thereof
11/06/2008CA2686125A1 Pseudopterosin-producing bacteria and methods of use
11/06/2008CA2685444A1 Rna antagonist compounds for the modulation of beta-catenin
11/06/2008CA2685425A1 Plant co2 sensors, nucleic acids encoding them, and methods for making and using them
11/06/2008CA2685409A1 High efficiency electroporation buffer
11/06/2008CA2685405A1 Modified phosphatases
11/06/2008CA2685400A1 Production of high mannose proteins in plant culture
11/06/2008CA2685394A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/06/2008CA2685376A1 Use of methylated or unmethylated line-1 dna as a cancer marker
11/06/2008CA2685326A1 Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
11/06/2008CA2685295A1 Hemipteran- and coleopteran- active toxin proteins from bacillus thuringiensis
11/06/2008CA2685209A1 Compositions, methods, and devices for isolating biological materials
11/06/2008CA2685136A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
11/06/2008CA2685099A1 Antibodies against ramp3
11/06/2008CA2685027A1 Peptide nucleic acid probes for analysis of certain staphylococcus species
11/06/2008CA2684724A1 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
11/06/2008CA2684378A1 Targeted integration into the ppp1r12c locus
11/06/2008CA2684038A1 Plants having improved growth characteristics under reduced nutrient availability and a method for making the same
11/06/2008CA2679658A1 Fusion proteins binding to growth factors
11/06/2008CA2676808A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf)
11/06/2008CA2669315A1 Ablative immunotherapy
11/06/2008CA2669049A1 Binary epitope antibodies and b cell superantigen immune stimulants
11/06/2008CA2667196A1 Random homozygous gene perturbation to enhance antibody production
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988176A1 Method of detecting acid-fast bacteria using ribosomal RNA as target
11/05/2008EP1988170A1 Method of producing chemical product and continuous fermentation apparatus
11/05/2008EP1988168A1 Means and methods for providing ribulose bisphosphate-carboxylase-oxygenase with improved properties
11/05/2008EP1988167A2 Inhibiting peptides
11/05/2008EP1988166A1 Human Toll-like receptor proteins, related reagents and methods
11/05/2008EP1988165A1 Isolated DNA encoding cullin regulator ROC1, isolated proteins encoded by the same, and methods utilizing the same
11/05/2008EP1988164A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor
11/05/2008EP1988163A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
11/05/2008EP1988162A1 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent
11/05/2008EP1988161A1 Method of changing fluorescence wavelength of fluoroprotein
11/05/2008EP1988157A1 Vitreous cell line
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988099A2 Bacillus thuringiensis insecticidal proteins
11/05/2008EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/05/2008EP1987845A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor.
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987359A2 Vascular tumor markers
11/05/2008EP1987178A2 Method of constructing and screening libraries of peptide structures
11/05/2008EP1987161A2 Method to identify cd40-sensitive cells
11/05/2008EP1987151A2 Lipoparticles comprising ion channels, methods of making, and using the same
11/05/2008EP1987150A2 Selection of host cells expressing protein at high levels
11/05/2008EP1987149A1 Brittle stalk 2 gene family and related methods and uses
11/05/2008EP1987148A1 De-differentiation of astrocytes into neural stem cell using bmi-1
11/05/2008EP1987147A2 Method for producing terpenes and mep-transformed microorganisms therefore
11/05/2008EP1987146A1 A method for generating reference controls for pharmacogenomic testing
11/05/2008EP1987145A2 Rna interference mediated inhibition of hepatitis c virus
11/05/2008EP1987144A1 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh
11/05/2008EP1987143A1 De-differentiation of astrocytes into neural stem cell using nanog
11/05/2008EP1987142A2 Esterases and related nucleic acids and methods
11/05/2008EP1987139A2 Novel oxidoreductases and uses thereof
11/05/2008EP1987137A1 Synthesis of sialic acid in plants
11/05/2008EP1987064A1 Domain antibody construct
11/05/2008EP1987061A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases
11/05/2008EP1987059A2 Adir related polymorphisms and applications thereof
11/05/2008EP1987041A1 Improved cephalosporin production
11/05/2008EP1986699A2 Rna interference agents for therapeutic use
11/05/2008EP1986696A2 Method for production of a transformed cell
11/05/2008EP1986681A2 Compositions and methods for modulating hemostasis using variant forms of activated factor v
11/05/2008EP1986676A2 Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments
11/05/2008EP1986667A1 Dendritic cells transiently transfected with a membrane homing polypeptide and their use
11/05/2008EP1986661A2 Gene therapy for niemann-pick disease type a
1 ... 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 ... 4023